Anemia in pediatric renal transplant recipients
- 1 May 2004
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (5) , 526-530
Abstract
The aim of this study was to establish the prevalence of anemia in stable pediatric renal transplant recipients and to examine the association of anemia with renal function, immunosuppressants, angiotensin converting enzyme inhibitors, and growth, as well as iron, vitamin B12, and folate stores. This is a cross-sectional study of the 50 renal transplant recipients currently followed at our center. Patient data were collected regarding hematological parameters, growth, medications, renal function, underlying renal disease, delayed graft function, episodes of rejection, and iron or erythropoietin therapy post transplantation. The mean hemoglobin level (Hb) was 110 g/l and the overall prevalence of anemia was 60%, including 30% who were severely anemic (HbPP=0.001). The dose of mycophenolate was positively correlated with Hb, but this was likely to be confounded by our practice of dose reduction in the setting of anemia. Angiotensin converting enzyme inhibitor use was not associated with anemia. Severely anemic patients tended to be shorter, with a mean Z-score for height of –1.8 compared with –0.9 for those with normal Hb (P=0.02). Anemia is a significant and common problem in pediatric renal transplant patients. Deteriorating renal function is an important cause, but other factors like iron deficiency and immunosuppression are involved. Definition of iron deficiency is difficult and serum iron may be a valuable indicator. Medication doses, nutritional status, need for erythropoietin and iron, as well as poor graft function and growth require systematic scrutiny in the care of the anemic renal transplant recipient.Keywords
This publication has 18 references indexed in Scilit:
- Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesisPediatric Transplantation, 2003
- Prevalence and Management of Anemia in Renal Transplant Recipients: A European SurveyAmerican Journal of Transplantation, 2003
- Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipientsAmerican Journal of Kidney Diseases, 2002
- Factors influencing growth and final height after renal transplantationPediatric Transplantation, 2002
- ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacyAmerican Journal of Kidney Diseases, 2000
- Effects of growth hormone in short children after renal transplantationPediatric Nephrology, 1998
- Does tacrolimus cause more severe anemia than cyclosporine A in children after renal transplantation?Transplant International, 1998
- Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipientsKidney International, 1996
- Final Height and Its Predictive Factors after Renal Transplantation in ChildhoodPediatric Research, 1994
- Growth hormone treatment in growth-retarded adolescents after renal transplantThe Lancet, 1994